Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs-Reference-Cited by-同舟云学术

Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs

Published:2021-10 Issue: Volume:96 Page:103469
ISSN:0955-3959
Container-title:International Journal of Drug Policy
language:en
Short-container-title:International Journal of Drug Policy

Author:

Grebely Jason,Collins Alexandra B.,Artenie Andreea Adelina,Sutherland Rachel,Meyer Jaimie P.,Barocas Joshua A.,Falade-Nwulia Oluwaseun,Cepeda Javier A.,Cunningham Evan B.,Hajarizadeh Behzad,Lafferty Lise,Lazarus Jeffrey V.,Bonn Matthew,Marshall Alison D.,Treloar Carla

Publisher

Elsevier BV

Subject

Health Policy,Medicine (miscellaneous)

Reference138 articles.

1. Hepatitis C elimination among people incarcerated in prisons: Challenges and recommendations for action within a health systems framework;Akiyama;Lancet Gastroenterology & Hepatology,2021

2. Patient and provider perceived barriers and facilitators to direct acting antiviral hepatitis C treatment among priority populations in high income countries: A knowledge synthesis;Amoako;International Journal of Drug Policy,2021

3. Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection;Artenie;International Journal of Drug Policy,2021

4. Progress and challenges of a pioneering hepatitis C elimination program in the country of Georgia;Averhoff;Journal of Hepatology,2020

5. Barriers and facilitators of access to HIV, harm reduction and sexual and reproductive health services by women who inject drugs: Role of community-based outreach and drop-in centers;Ayon;AIDS Care,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subspecialty physicians’ perspectives on barriers and facilitators of hepatitis C treatment: a qualitative study;Harm Reduction Journal;2024-07-25

2. Applying a stigma and time framework to facilitate equitable access to hepatitis C care among women who inject drugs: The ETHOS Engage Study;International Journal of Drug Policy;2024-07

3. Pilot study of a community pharmacist led program to treat hepatitis C virus among people who inject drugs;Drug and Alcohol Dependence Reports;2024-03

4. “Apparently, you can only be treated once”: A qualitative study exploring perceptions of hepatitis C and access to treatment among people who inject drugs visiting a needle and syringe program;International Journal of Drug Policy;2023-11

5. Impact of safer supply programs on injection practices: client and provider experiences in Ontario, Canada;Harm Reduction Journal;2023-06-28